Literature DB >> 8830903

Social identities and response to treatment for alcohol and cocaine abuse.

C Weisz1.   

Abstract

This study examined the relationship between social identities and response to treatment for alcohol and/or cocaine abuse. Individuals who reported more valued (i.e., positive and important) social identities were expected to have better treatment outcomes. Forty-five participants were interviewed at treatment entry and at 3 and 6 months after starting treatment. The number of valued identities increased between treatment entry and 3 months. Participants with a greater number of valued identities at treatment entry were more likely to be abstinent at 3 months. Participants who reported more interference between substance use and valued identities were also more likely to be abstinent at 3 months, suggesting a possible motivational mechanism for the link between identities and response to treatment. Neither number of valued identities nor conflict between substance use and identities predicted abstinence between 3 and 6 months. Interaction effects, specific identities, and protective and motivational functions of social identities are discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8830903     DOI: 10.1016/0306-4603(95)00075-5

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  3 in total

1.  Self-referent constructs and medical sociology: in search of an integrative framework.

Authors:  Howard B Kaplan
Journal:  J Health Soc Behav       Date:  2007-06

2.  Does Gambling Identity Predict Unique Variance in Negative Gambling-Related Outcomes: An Examination of Direct and Interactive Associations.

Authors:  Kevin S Montes
Journal:  J Gambl Stud       Date:  2020-12

3.  Associations between social identity diversity, compatibility, and recovery capital amongst young people in substance use treatment.

Authors:  E Mawson; D Best; D I Lubman
Journal:  Addict Behav Rep       Date:  2016-10-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.